Abstract:Background Epigallocatechin-3-gallate (EGCG) has been demonstrated to have anti-neoplastic activity, but the effective concentration of EGCG and its possible mechanisms are uncertain. The study on the killing effects of EGCG on different digestive tract cancer cell lines can find target sites of its anti-neoplastic effect and provide a theoretical basis for its clinical application in the treatment of cancers.Methods Methyl thiazolyl tetrazolium (MTT) analysis was made to detect the differential sensitivities of eight digestive tract cancer cell lines to EGCG. The effect of EGCG on cell cycle distribution of sensitive cancer cell line was measured by flow cytometry. By polymerase chain reaction (PCR)-enzyme linked inummosorbent assay (ELISA) protocol, the influence of EGCG on telomerase activity of sensitive cancer cell line was also investigated. RT-PCR method was employed to detect the influence of EGCG on the expressions of hTERT, c-myc, p53 and mad1 genes in sensitive cancer cell line.Results EGCG exhibited dose-dependent killing effects on all eight disgestive tract cancer cell lines. The 50% inhibitory concentration (IC50) of SW1116, MKN45, BGC823, SGC7901, AGS, MKN28, HGC27 and LoVo cells were 51.7 mu mol/L, 55.9 mu mol/L, 68.5 mu mol/L, 79.1 mu mol/L, 83.8 mu mol/L, 119.8 mu mol/L, 183.2 mu mol/L and 194.6 mu mol/L, respectively. There were no apparent changes in cell cycle distribution of sensitive cancer cell line MKN45 48 hours after incubating with three different concentrations of EGCG compared with the controls. It was found that EGCG could suppress the telomerase activity of MKN45 cells, and the effects were dose- and time-dependent. After EGCG administration, the expression of hTERT and c-myc genes in MKN45 cells was decreased, that of the mad1 gene increased, and that of the p53 gene unchanged.Conclusions EGCG has dose-dependent killing effects on different digestive tract cancer cell lines. Administration of EGCG has no obvious effect on cell cycle distribution of sensitive cancer cell line MKN45. The anti-neoplastic activity of EGCG might be due to the inhibition of telomerase activity by means of its influence on hTERT and the up-stream regulation genes.

Study of Epigallocatechin - 3 - Gallate to SW480 and LoVo Colorectal Cancer Cells

Epigallocatechin-3-gall-ate on Colorectal Cancer Cells in Vitro

Epigallocatechin Gallate Inhibits the Proliferation of Colorectal Cancer Cells by Regulating Notch Signaling

[Inhibitory Effect and Mechanism of (-)-epigallocatechin-3-gallate on HT29 and HCT-8 Colorectal Cancer Cell Lines and Expression of HES1 and JAG1].

Tea polyphenol EGCG inhibited colorectal-cancer-cell proliferation and migration via downregulation of STAT3

Effects of Epigallocatechin-3-gallate on Human Colon Cancer Cell Line HT-29 in Vitro

Molecular mechanism of epigallocatechin-3-gallate in human esophageal squamous cell carcinoma in vitro and in vivo.

(-)-Epigallocatechin-3-gallate and EZH2 inhibitor GSK343 have similar inhibitory effects and mechanisms of action on colorectal cancer cells.

Effect of Epigallocatechin-3-Gallate on the Expression of EGFR,67LR and VEGF in Human Tongue Squamous Cell Carcinoma Cell Line CAL-27

Inhibitory Effects of (−)-Epigallocatechin-3-gallate on Esophageal Cancer

The Effect of Different Treatments of (-)-Epigallocatechin-3-Gallate on Colorectal Carcinoma Cell Lines.

Experimental Study On Anti-Neoplastic Activity Of Epigallocatechin-3-Gallate To Digestive Tract Carcinomas

Inhibitory Effect of Epigallocatechin Gallate on the Proliferation of Lewis Lung Cancer Mice and A549 and Calu-3 Lung Cancer Cells

Cyclin D1 Degradation and P21 Induction Contribute to Growth Inhibition of Colorectal Cancer Cells Induced by Epigallocatechin-3-gallate

(−)-Epigallocatechin-3-gallate derivatives combined with cisplatin exhibit synergistic inhibitory effects on non-small-cell lung cancer cells

Epigallocatechin Gallate-Β-lactoglobulin Nanoparticles Improve the Antitumor Activity of EGCG for Inducing Cancer Cell Apoptosis

The inhibitory effect of epigallocatechin-3-gallate on human osteosarcoma cell proliferation and its mechanism

Effects of Blocking EGFR and IGFR-1β Activation on Cell Cycle and Apoptosis of Colorectal Cancer Cells

Molecular mechanisms underlying the epigallocatechin-3-gallate-mediated inhibition of oral squamous cell carcinogenesis

In vitro effect of DNA methyltransferase inhibitor on proliferation, apoptosis and cell cycle of colon cancer cells

Epigallocatechin gallate (EGCG) suppresses growth and tumorigenicity in breast cancer cells by downregulation of miR-25